gamma-secretase modulator 1

CAS No. 1172637-87-4

gamma-secretase modulator 1( N-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine )

Catalog No. M26225 CAS No. 1172637-87-4

gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 43 In Stock
10MG 77 In Stock
25MG 151 In Stock
50MG 237 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    gamma-secretase modulator 1
  • Note
    Research use only, not for human use.
  • Brief Description
    gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
  • Description
    gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine
  • Pathway
    Neuroscience
  • Target
    Gamma-secretase
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1172637-87-4
  • Formula Weight
    416.54
  • Molecular Formula
    C24H24N4OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(Nc2nc3C(CCCc3s2)c2ccccc2)ccc1-n1cnc(C)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huang J, Zhou Z, Zhou M, Miao M, Li H, Hu Q. Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout. Bioorg Med Chem. 2018 May 1;26(8):1653-1664.
molnova catalog
related products
  • Jagged-1 188-204

    This peptide is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-αB activation.

  • Brontictuzumab

    Brontictuzumab (OMP 52M5) is a monoclonal antibody that targets Notch1 and inhibits activation of the pathway.

  • NVP-TNKS656

    NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor.